Martin, MD
Bradley Martin, Monkton, MD US
Patent application number | Description | Published |
---|---|---|
20150339937 | METHODS AND SYSTEMS FOR TESTING WITH TEST BOOKLETS AND ELECTRONIC DEVICES - Methods and systems for testing with test booklets and electronic devices are disclosed. In one aspect, a computer-assisted testing method and system is provided. A paper-delivered examination is used and includes an examination booklet and a plurality of test items. Solutions are entered into an electronic answer sheet for the test items in the examination booklet. An electronic attendance request from a student can be confirmed by granting the student access to an electronic response sheet corresponding to the paper-delivered exam. Student responses to the plurality of test items in the paper-delivered exam can be entered in the electronic response sheet. | 11-26-2015 |
Bradley J. Martin, Ellicot City, MD US
Patent application number | Description | Published |
---|---|---|
20120213749 | CARDIAC MUSCLE REGENERATION USING MESENCHYMAL STEM CELLS - Disclosed is a method for repairing or regenerating blood vessels in the heart of an individual, method of stimulating or promoting angiogenesis in the heart of an individual, or method of stimulating or promoting vascular endothelial growth factor (VEGF) expression in a heart of an individual by administering to the individual an effective amount of mesenchymal stem cells. These cells can be administered as a liquid injectable. | 08-23-2012 |
Bradley J. Martin, Ellicott City, MD US
Patent application number | Description | Published |
---|---|---|
20090214493 | Cardiac Muscle Regeneration Using Mesenchymal Stem Cells - Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectable or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation. | 08-27-2009 |
20110158964 | Cardiac Muscle Regeneration Using Mesenchymal Stem Cells - Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation. | 06-30-2011 |
20110158965 | Cardiac Muscle Regeneration Using Mesenchymal Stem Cells - Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation. | 06-30-2011 |
20120141437 | Cardiac Muscle Regeneration Using Mesenchymal Stem Cells - Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation. | 06-07-2012 |
20120207716 | Cardiac Muscle Regeneration Using Mesenchymal Stem Cells - Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation. | 08-16-2012 |
Brian M. Martin, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20120225049 | FAST ACTING SNARE-CLEAVING ENZYMES - The present invention relates to metalloprotease enzymes isolated from scorpion venom, their nucleic acid and amino acid sequences, and methods of use thereof in the treatment of various diseases, disorders and cosmetic conditions. | 09-06-2012 |
Bryan J. Martin, Perry Hall, MD US
Patent application number | Description | Published |
---|---|---|
20140297510 | METHOD AND SYSTEM FOR VENDOR-NEUTRAL SUBCONTRACTOR ENABLEMENT - A method implemented in a computer infrastructure having computer executable code, includes receiving information in support of a bid and determining if value-add eligibility criteria is met. Additionally, the method includes calculating a bid price based on the information if the value-add eligibility criteria is met, updating a record indicating the bid price and tracking additions and changes to the record. | 10-02-2014 |
Carolyn Martin, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20080244858 | HAND VACUUM WITH FILTER INDICATOR - A hand-held portable vacuum having a filter indicator that is coupled to an outlet housing and in fluid communication with a portion of the outlet housing between a fan inlet and an intake. The filter indicator includes a pressure differential indicator that is configured to indicate a pressure differential between air in the portion of the outlet housing and atmospheric air pressure. The filter indicator is employed to indicate to the user of the hand-held vacuum that replacement and/or cleaning of the filter is required. The vacuum may also be used in a blower mode with a set of inflator nozzles to permit a user to inflate an article. | 10-09-2008 |
Carolyn M. Martin, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20080202909 | REMOTE CONTROLLED WALL SWITCH ACTUATOR - A device to actuate a switch. The switch has a switch toggle movable between a first position and a second position. The device includes a switch yoke movable between the first position and the second position adapted to engage the switch toggle and move therewith. The device also includes a first linkage connected to the switch yoke. The first linkage applies a force in response to an input signal to move the switch yoke from the first position to the second position. The first linkage includes a shape memory alloy. The device is configured to permit manual actuation of the switch toggle. | 08-28-2008 |
Christy Martin, Edgewater, MD US
Patent application number | Description | Published |
---|---|---|
20140050903 | Method of Printing a Conductive Article and Articles Made Thereby - A method of printing articles having variable conductivities, including those having conductivity gradients. | 02-20-2014 |
Curtis A. Martin, Damascus, MD US
Patent application number | Description | Published |
---|---|---|
20100236393 | Composite Armor Including Geometric Elements for Attenuating Shock Waves - The present invention's stratified composite material system of armor, as typically embodied, comprises a strike stratum and a backing stratum. The strike stratum includes elastomeric matrix material and inventive ceramic-inclusive elements embedded therein and arranged (e.g., in one or more rows and one or more columns) along a geometric plane corresponding to the front (initial strike) surface of the strike stratum. More rigid than the strike stratum, the backing stratum is constituted by, e.g., metallic (metal or metal alloy) material or fiber-reinforced polymeric matrix material. Some inventive embodiments also comprise a spall-containment stratum fronting the strike stratum. The inventive ceramic-inclusive elements geometrically describe any of various inventive modes, including: first mode, having a flat front face and a textured back face; second mode, having a pyramidal front section and a prismatoidal (especially, prismoidal, e.g., truncated pyramidal or prismatic) body section; hybrid mode, combining features of first and second modes. | 09-23-2010 |
David Christian Martin, Reisterstown, MD US
Patent application number | Description | Published |
---|---|---|
20090064567 | Biological oils and production and uses Thereof - The present invention provides biological oils and methods and uses thereof. The biological oils are preferably produced by heterotrophic fermentation of one or more microorganisms using cellulose-containing feedstock as a main source of carbon. The present invention also provides methods of producing lipid-based biofuels and food, nutritional, and pharmaceutical products using the biological oils. | 03-12-2009 |
20120272566 | Biological Oils and Production and Uses Thereof - The present invention provides biological oils and methods and uses thereof. The biological oils are preferably produced by heterotrophic fermentation of one or more microorganisms using cellulose-containing feedstock as a main source of carbon. The present invention also provides methods of producing lipid-based biofuels and food, nutritional, and pharmaceutical products using the biological oils. | 11-01-2012 |
20120323029 | Methods, Biological Oils, Biofuels, Units, and Organisms Related to Use in Compression Engines - Methods, biological oils, biofuels, units, and/or organisms directed to use in compression engines. A method of producing biological oils includes producing an organism and having the organism consume a feedstock. The organism includes a lipid containing fatty acids. The organism meets or exceeds at least two metrics. The metrics include: A) a cell density of at least about 115 grams per liter; B) a fatty acid content of at least about 49 percent on a dry mass basis; C) a fatty acid productivity of at least about 15 grams per liter per day; D) a fatty acid yield of at least about 0.175 grams of fatty acids produced per grams of the feedstock consumed; E) a 24 hour peak fatty acid productivity of at least about 30 grams per liter per day; F) an extraction efficiency on a percent of total fatty acid content basis of at least about 50 percent; and/or G) yield of fatty acids on oxygen of more than about 0.4 as grams of fatty acids produced per gram of oxygen consumed basis. | 12-20-2012 |
David Elan Martin, Potomac, MD US
Patent application number | Description | Published |
---|---|---|
20160074812 | Energy-Efficient Conductive-Gap Membrane Distillation - Apparatus for energy-efficient conductive-gap membrane distillation includes a feed-liquid source and a distillation module. The distillation module includes a feed-liquid chamber in fluid communication with the feed-liquid source. The feed-liquid chamber includes a selectively porous material that allows a component of the feed liquid to pass through the selectively porous material and exit the feed-liquid chamber in vapor form but not in liquid form. The distillation module also includes a conductive-gap chamber adjacent to the selectively porous material on an opposite side of the selectively porous material from the feed-liquid chamber; a heat-transfer surface maintained at a lower temperature than the feed liquid in the feed-liquid chamber, wherein the heat-transfer surface is in thermal contact with the conductive-gap chamber; and a thermally conductive material extending across the conductive-gap chamber. | 03-17-2016 |
David Eugene Martin, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20120214775 | Pharmaceutical Salts of 3-O-(3',3'-Dimethylsuccinyl) Betulinic Acid - Salts of 3-O-(3′,3′-dimethylsuccinyl)Betulinic acid (DSB) are disclosed. Particularly, the preparation, pharmaceutical evaluation, and in vivo bioavailability evaluation of N-methyl-D-glucamine and alkali metal salt forms of DSB are disclosed. Pharmaceutical compositions including these salt forms are used in methods of treating HIV and related diseases. Methods of making the salts of DSB and the pharmaceutical compositions are also provided. | 08-23-2012 |
David Z. Martin, Towson, MD US
Patent application number | Description | Published |
---|---|---|
20130324980 | METHOD AND APPARATUS FOR FACILITATING ACCESS THROUGH A PATIENT TISSUE - A system for facilitating access through a substantially planar and laterally oriented patient skin surface includes a guiding substrate extending substantially parallel to the skin surface and selectively directly fastened thereto. The guiding substrate supports a guiding structure in a substantially fixed relationship to an access site of the skin surface. A tool carriage is configured to accept surgical tools for sequential interaction with the access site. The tool carriage engages the guiding structure such that the tool carriage is guided along a predetermined action path when motive force is provided to the tool carriage. The tool carriage is guided along the action path with an incising tool in penetrating contact with the access site of the skin surface to create a laterally elongate incision at the access site. The tool carriage is guided along the action path to substantially close the incision at the access site. | 12-05-2013 |
Farrel Martin, Waldorf, MD US
Patent application number | Description | Published |
---|---|---|
20130248382 | Selective Masking by Photolithography (SMP) for Making Electrochemical Measurements - A method for isolating microstructural regions or features on a surface for electrochemical experimentation comprising polishing a metal sample, coating the metal sample with a photoresist, selecting a region of interest of the metal sample, exposing the region of interest with light energy, developing the exposed photoresist and creating a developed region. | 09-26-2013 |
George Martin, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20120065703 | Conductive Biopolymer Implant For Enhancing Tissue Repair And Regeneration Using Electromagnetic Fields - Embodiments of the present invention relate generally to the field of tissue repair and regeneration. More specifically, embodiments of the present invention relate to medical devices, materials or constructs, such as conductive biocompatible polymers having one or more networks of metal nanowires that enhance tissue repair and regeneration using electromagnetic fields. | 03-15-2012 |
George R. Martin, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20100036098 | BIOCOMPOSITES AND METHODS OF MAKING THE SAME - In general, the present invention is related to biopolymer and biocomposite materials and structures, and methods of making and using the same. In some embodiments, the present invention is directed to oriented collagen based biocomposite materials and structures, and methods of making. | 02-11-2010 |
20110097358 | RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs) - Respiratory syncytial virus (RSV) virus-like particles (VLPs) comprising at least one RSV protein are described. Also described are compositions comprising these VLPs as well as methods of making and using these VLPs. | 04-28-2011 |
20110212128 | Universal virus-like particle (VLP) influenza vaccines - Described herein are influenza virus-like particles (VLPs) that display on truncated, re-engineered or remodeled HA molecules on their surface. Also described are methods of making and using these VLPs. | 09-01-2011 |
20130287744 | Biocomposites And Methods Of Making The Same - In general, the present invention is related to biopolymer and biocomposite materials and structures, and methods of making and using the same. In some embodiments, the present invention is directed to oriented collagen based biocomposite materials and structures, and methods of making. | 10-31-2013 |
20140081070 | Biodegradable Multilayer Constructs - Embodiments of the present invention relate generally to the field of tissue repair and regeneration. More specifically embodiments of present disclosure relate to devices or constructs and methods to prepare various devices or constructs useful in directing cellular repair and controlling tissue regeneration to prevent or minimize postsurgical or post traumatic adhesions, excessive scars and/or fibrotic reactions of injured tissues. | 03-20-2014 |
20140242347 | Graft For Directed Vascular And Lymphatic Regeneration And Methods To Guide Endothelial Cell Assembly - Embodiments of the present invention relate to a therapeutic device (graft) comprising a collagen membrane having an aligned uniaxial or biaxial structure such that mammalian cells plated on the membrane align mainly along the direction of the collagen fibrils. In a further aspect, a graft comprising a substantially tubular body, wherein the body has an exterior surface, an interior surface, and at least one lumen extending therethrough such that a fluid flow through the lumen can direct mammalian cell migration. In a further aspect, mammalian cells or growth and angiogenic factors can be optionally attached to the exterior and/or interior surface of the substantially tubular body. In various aspects, the graft can be used as a vascular prosthesis, a stent, or a nerve regeneration scaffold. Methods of preparing and implanting same are also provided. | 08-28-2014 |
20150283069 | INHALABLE VACCINE COMPOSITIONS AND METHODS - Dry powder inhalable compositions and methods for using and making the compositions are disclosed for vaccinating a subject against disease. In particular, the compositions are inhalable dry powders useful for preventing and/or treating diseases caused by microorganisms, for example, microorganisms such as viral or bacterial pathogens, including, the influenza virus. In particular, the method comprises the administration of an inhalable composition comprising virus-like particles and/or specific protein/s or antigenic peptides, peptide fragments and/or derivatives thereof using a dry powder drug delivery system. | 10-08-2015 |
20160101150 | PEPTIDES HAVING ANTI-INFLAMMATORY PROPERTIES - Aspects of the present invention relate to peptides having anti-inflammatory activity, compositions containing one or more of the peptides, and use of the peptides to treat conditions associated with excessive inflammation in animals, particularly humans and other mammals. | 04-14-2016 |
Howard Martin, Potomac, MD US
Patent application number | Description | Published |
---|---|---|
20120087993 | BIOCIDAL ALDEHYDE COMPOSITION FOR OIL AND GAS EXTRACTION - A combination biocide (Glutaraldehyde or OPA), quaternary phosphonium biocide (preferably TTPC), alcohol (preferably isopropyl alcohol), and functional excipients for the oil and gas recovery industry. The functional excipients for the oil and gas recovery industry are a cellulose type proppant, a poloxamer wetting agent, a friction-reducing pluronic block copolymer, a drag reducing agent such as polyethylene oxide, and a flocculating agent. The OPA may be of the dialdehyde C | 04-12-2012 |
20120101063 | BIOCIDAL ALDEHYDE COMPOSITION - A combination biocide (Glutaraldehyde or OPA), quaternary phosphonium biocide, alcohol, and functional excipients for surface-sterilization of medical instruments and other objects. The quaternary phosphonium biocide is preferably TTPC, and the alcohol isopropyl alcohol. The OPA is the dialdehyde C | 04-26-2012 |
20130251822 | BIOCIDAL ALDEHYDE COMPOSITION - A combination biocide (Glutaraldehyde or OPA), quaternary phosphonium biocide, alcohol, and functional excipients for surface-sterilization of medical instruments and other objects. The quaternary phosphonium biocide is preferably TTPC, and the alcohol isopropyl alcohol. The OPA is the dialdehyde C | 09-26-2013 |
20130259953 | BIOCIDAL ALDEHYDE COMPOSITION FOR OIL AND GAS EXTRACTION - A combination biocide (Glutaraldehyde or OPA), quaternary phosphonium biocide (preferably TTPC), alcohol (preferably isopropyl alcohol), and functional excipients for the oil and gas recovery industry. The functional excipients for the oil and gas recovery industry are a cellulose type proppant, a poloxamer wetting agent, a friction-reducing pluronic block copolymer, a drag reducing agent such as polyethylene oxide, and a flocculating agent. The OPA may be of the dialdehyde C | 10-03-2013 |
20150157024 | BIOCIDAL ALDEHYDE COMPOSITION FOR WATER MANAGEMENT - A combination biocide including OPA, quaternary phosphonium biocide (TTPC), alcohol (preferably isopropyl alcohol), and functional excipients for use in the oil and gas recovery industry or for vessel ballast water treatment. The functional excipients for the oil and gas recovery industry are an optional cellulose type proppant, a poloxamer wetting agent, a friction-reducing pluronic block copolymer, a drag reducing agent such as polyethylene oxide, and a flocculating agent. The proppant is unnecessary for vessel ballast water treatment. In both applications the OPA is the dialdehyde C | 06-11-2015 |
Howard Martin, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20110059027 | Biocidal aldehyde composition - A novel combination of OPA, a surfactant, and alcohol. The surfactant is preferably a dual chain quaternary ammonium compound consisting of a mixture of alkyl dimethyl-benzylammonium chlorides and alkyl dimethylethylbenzylammonium, that absorbs onto a surface and alters the free energy of that surface. The alcohol is preferably isopropyl alcohol. The OPA is the dialdehyde C | 03-10-2011 |
20110060052 | Biocidal aldehyde composition for oil and gas extraction - A novel combination of a biocide (Glutaraldehyde or OPA), a surfactant, alcohol, and functional excipients for the oil and gas recovery industry. The surfactant is preferably a dual chain quaternary ammonium compound consisting of a mixture of alkyl dimethy-benzylammonium chlorides and alkyl dimethylethylbenzylammonium, that absorbs onto a surface and alters the free energy of that surface. The alcohol is preferably isopropyl alcohol. The functional excipients for the oil and gas recovery industry are a cellulose type proppant, a poloxamer wetting agent, a friction-reducing pluronic block copolymer, a drag reducing agent such as polethylene oxide, and a flocculating agent. The biocide may be OPA of the dialdehyde C | 03-10-2011 |
James A. Martin, Bel Air, MD US
Patent application number | Description | Published |
---|---|---|
20100292845 | ENHANCED AZIMUTH ANTENNA CONTROL - An assembly that has a rotator element, a sensor element coupled to the rotator element or assembly, and a controller element provides azimuth antenna control. The rotator element has a worm gear driven slewing ring having a through hole through which a feed line to an antenna may be inserted to accommodate continuous rotation of greater than 360 degrees or partial rotation in either direction of the antenna coupled to the rotator element. The controller element is coupled to the rotator element and to the sensor element, and the controller element receives feedback information concerning a current azimuth position of the antenna from the sensor element to control the rotator element to rotate to a future azimuth position of the antenna in accordance with a selected azimuth function and the feedback information provided by the sensor element. | 11-18-2010 |
Jeremy Martin, North Potomac, MD US
Patent application number | Description | Published |
---|---|---|
20090012747 | Multiple Line Width Electromigration Test Structure and Method - Apparatus and methods pertaining to examining electromigration lifespan are disclosed. In one aspect, a method of manufacturing is provided that includes forming a test structure on a semiconductor substrate. The test structure includes a first conductor structure that has a first cross-sectional area and a second conductor structure that has a second cross-sectional area larger than the first cross-sectional area. Current is flowed through the first and second conductor structures at current densities sufficient to cause electromigration in the first and second conductor structures. The current is monitored for drops indicative of electromigration failure of one or both of the first and second conductor structures. The time elapsed before the failure of the one or both of the conductor structures is recorded. | 01-08-2009 |
Jose Martin, Stevensville, MD US
Patent application number | Description | Published |
---|---|---|
20120093996 | SOUP PREPARING AND DISPENSING MACHINE (SPDM) AND METHOD OF PRODUCING INDIVIDUAL SERVINGS OF HOT OR COLD SOUP USING THE SAME - Hot or Cold soup made fresh from scratch, can or concentrate is prepared in a suitable container and after its preparation is kept cool, blended and re-circulated for long term shelf life until a serving is requested. This serving volume of soup is automatically pumped and heated to serving temperature (hot soup) and served in a suitable container like a cup or a bowl. The entire system where the soup resides is always kept refrigerated. The only portion of the soup that is heated after its preparation is the one dispensed. If it is a soup that is served cold the heating prior to dispensing is by-passed. | 04-19-2012 |
Jose V. Martin, Stevensville, MD US
Patent application number | Description | Published |
---|---|---|
20080208468 | Forward looking virtual imaging - Inputting information from On-Board Avionics & Instrumentation and may be AHRS which provides vehicle status to a FLVI Engine through a communication interface, the FLVI engine selects imagery from a data base and synchronizes the imagery with the vehicle status, and outputs the synchronized images to a display. The FLVI engine may have a calibration module. | 08-28-2008 |
Mark Martin, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20080248489 | METHODS AND COMPOSITIONS FOR DIRECTED MICROWAVE CHEMISTRY - The present invention concerns a novel means by which specific chosen reactions can be accelerated through the use of a new type of artificial enzyme. The invention allows specific reactions to occur at an accelerated rate, even in the presence of other non-chosen molecules, which may be very similar in structure to the chosen reactant. The reactions may be stoichiometric or catalytic. | 10-09-2008 |
20090170121 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME - Compositions, reagents, kits, systems, system components, and methods for performing assays. More particularly, the invention relates to the use of novel combinations of reagents to provide improved assay performance. | 07-02-2009 |
20140336070 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME - The invention relates to improved electrochemiluminescence assay methods for phosphorylated peptides or proteins employing phospho-specific antibodies and buffer compositions that are substantially free of inorganic phosphate. | 11-13-2014 |
Mark N. Martin, Ellicott City, MD US
Patent application number | Description | Published |
---|---|---|
20120007559 | Device and Control Algorithm for Continuously Equalizing the Charge State of Lithium Ion Battery Cells - A method of equalizing charge states of individual cells in a battery includes measuring a previous cell voltage for each cell, measuring a previous shunt current for each cell, calculating, based on the previous cell voltage and the previous shunt current, an adjusted cell voltage for each cell, determining a lowest adjusted cell voltage from among the calculated adjusted cell voltages, and calculating a new shunt current for each cell. | 01-12-2012 |
Mark T. Martin, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20100140086 | Methods and apparatus for improved luminescence assays using microparticles - A method and apparatus for performing electrochemiluminescence assays are presented. In exemplary embodiments of the present invention an apparatus comprises an ECL-inactive electrode surface having a first assay-ligand immobilized thereon and an ECL-active microparticle having a second assay ligand immobilized thereon. In exemplary embodiments of the present invention a method comprises (a) forming a mixture comprising an electrochemiluminescent label and a microparticle having a first assay-ligand immobilized thereon, (b) applying electrochemical energy to an electrode surface in the presence of said mixture, and (c) measuring emitted electrochemiluminescence, where the microparticle is ECL-active and where the electrode surface is ECL-inactive when electrochemical energy is applied to it in the presence of said mixture. | 06-10-2010 |
20110124116 | MULTI-ARRAY, MULTI-SPECIFIC ELECTROCHEMILUMINESCENCE TESTING - Materials and methods are provided for producing patterned multi-array, multi-specific surfaces for use in diagnostics. The invention provides for electrochemiluminescence methods for detecting or measuring an analyte of interest. It also provides for novel electrodes for ECL assays. Materials and methods are provided for the chemical and/or physical control of conducting domains and reagent deposition for use multiply specific testing procedures. | 05-26-2011 |
20120165209 | METHODS AND COMPOSITIONS FOR DIRECTED MICROWAVE CHEMISTRY - The present invention concerns a novel means by which chemical preparations can be made. Reactions can be accelerated on special cartridges using microwave energy. The chips contain materials that efficiently absorb microwave energy causing chemical reaction rate increases. The invention is important in many chemical transformations including those used in protein chemistry, in nucleic acid chemistry, in analytical chemistry, and in the polymerase chain reaction. | 06-28-2012 |
20140274805 | MULTI-ARRAY, MULTI-SPECIFIC ELECTROCHEMILUMINESCENCE TESTING - Materials and Methods are provided for producing patterned multi-array, multi-specific surfaces for use in diagnostics. The invention provides for electrochemiluminescence methods for detecting or measuring an analyte of interest. It also provides for novel electrodes for ECL assays. Materials and methods are provided for the chemical and/or physical control of conducting domains and reagent deposition for use multiply specific testing procedures. | 09-18-2014 |
Michael Burgess Martin, Germantown, MD US
Patent application number | Description | Published |
---|---|---|
20090174705 | Parallax scanning through scene object position manipulation - One aspect of the invention includes a method of generating virtual autostereoscopic images using a computer. The method may include defining at least one object in a virtual three-dimensional space and defining a virtual point of view. Images may be generated by simulating a parallax scanning motion of the at least one object. The generated images can be displayed and stored. | 07-09-2009 |
20120176479 | Critical Alignment of Parallax Images for Autostereoscopic Display - A method is provided for generating an autostereoscopic display. The method includes acquiring a first parallax image and at least one other parallax image. At least a portion of the first parallax image may be aligned with a corresponding portion of the at least one other parallax image. Alternating views of the first parallax image and the at least one other parallax image may be displayed. | 07-12-2012 |
20150116466 | CRITICAL ALIGNMENT OF PARALLAX IMAGES FOR AUTOSTEREOSCOPIC DISPLAY - A method is provided for generating an autostereoscopic display. The method includes acquiring a first parallax image and at least one other parallax image. At least a portion of the first parallax image may be aligned with a corresponding portion of the at least one other parallax image. Alternating views of the first parallax image and the at least one other parallax image may be displayed. | 04-30-2015 |
Nathan Martin, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20110126385 | Security Clasp - One aspect of the present invention includes a first component that includes a solid body including a first and second aperture, a lip, and a groove. Also included is a second component that also includes an aperture corresponding to the first aperture of the first component. The second component is preferably operatively connected to and slidingly engageable with the first component. Finally, a third component is also included having a first end movably connected to the first component and a second free end operable to be engaged with the second aperture formed in the first component. When the free end of the third component is positioned within the second aperture of the first component, and when the second component is engaged with the lip and the groove of the first component, a flange of the second component prevents the free end of the third component from being removed from the second aperture of the first component. | 06-02-2011 |
Paul D. Martin, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20130326579 | HEALTHCARE PRIVACY BREACH PREVENTION THROUGH INTEGRATED AUDIT AND ACCESS CONTROL - A computer-implemented method for compliance with a privacy requirement. The method comprises analyzing, using one or more processors, an access log related to a history of users accessing records; deriving a plurality of roles assigned to the users and a plurality of accesses reflecting actions taken by the users; and deriving from the access log a mapped log comprising a plurality of mapping records including a plurality of mapped role-access pairs. The method further comprises generating, using the one or more processors, a reduced log including a plurality of reduced records comprising a mapped role-access pair and statistics that are associated with the mapped role-access pair, the statistics being derived from a subset of the mapping records that include the mapped role-access pair; and deriving an access policy based on the reduced log, wherein the access policy includes a plurality of proposed role-access pairs. | 12-05-2013 |
20150163252 | Healthcare Privacy Breach Prevention Through Integrated Audit and Access Control - A computer-implemented method for compliance with a privacy requirement. The method comprises analyzing, using one or more processors, an access log related to a history of users accessing records; deriving a plurality of roles assigned to the users and a plurality of accesses reflecting actions taken by the users; and deriving from the access log a mapped log comprising a plurality of mapping records including a plurality of mapped role-access pairs. The method further comprises generating, using the one or more processors, a reduced log including a plurality of reduced records comprising a mapped role-access pair and statistics that are associated with the mapped role-access pair, the statistics being derived from a subset of the mapping records that include the mapped role-access pair; and deriving an access policy based on the reduced log, wherein the access policy includes a plurality of proposed role-access pairs. | 06-11-2015 |
Richard W. Martin, Laurel, MD US
Patent application number | Description | Published |
---|---|---|
20090020181 | Remote fill head with automatic drip tray - A fill head for depositing hazardous waste materials into a container movable between a filling position seated on the container, and a container exchange position withdrawn from the container; a control arm carried by the fill head directing movement of the fill head between the filling and exchange positions; a drip tray movably carried on a support platform adjacent the fill head for extending underneath the fill head to retain drippings of the hazardous waste material from the fill head when in the exchange position; and, a lifting arm carried by the drip tray engaging the control arm, wherein the lifting arm biases the control arm to raise the fill head from the filling position to the exchange position when the drip tray is extended underneath the fill head so that as the fill head is withdrawn from the container any dripping hazardous waste is captured by the drip tray. | 01-22-2009 |
Roland Martin, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20090175823 | METHOD OF TREATING AUTOIMMUNE DISEASES WITH INTERFERON-BETA AND IL-2R ANTAGONIST - Disclosed is a method of administering an interleukin-2 receptor (IL-2R) antagonist to a subject to treat an autoimmune disease. In particular embodiments, the IL-2R antagonist is an anti-IL-2R monoclonal antibody specific for one or more chains of the IL-2R, such as the alpha-chain, for example daclizumab. In other particular embodiments the autoimmune disease is multiple sclerosis. In certain embodiments administration of interferon-beta is combined with administration of an antagonist of the IL-2R to provide significant clinical improvement in a subject with an autoimmune disease. | 07-09-2009 |
20130017152 | METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS - A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of an IL-21 receptor antagonist, wherein the subject has failed to respond treatment with beta interferon, thereby treating the subject. | 01-17-2013 |
20130095069 | METHOD OF TREATING AUTOIMMUNE DISEASES WITH INTERFERON-BETA AND IL-2R ANTAGONIST - Disclosed is a method of administering an interleukin-2 receptor (IL-2R) antagonist to a subject to treat an autoimmune disease. In particular embodiments, the IL-2R antagonist is an anti-IL-2R monoclonal antibody specific for one or more chains of the IL-2R, such as the alpha-chain, for example daclizumab. In other particular embodiments the autoimmune disease is multiple sclerosis. In certain embodiments administration of interferon-beta is combined with administration of an antagonist of the IL-2R to provide significant clinical improvement in a subject with an autoimmune disease. | 04-18-2013 |
20150337044 | Methods for the Treatment of Multiple Sclerosis - A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of an IL-21 receptor antagonist, wherein the subject has failed to respond treatment with beta interferon, thereby treating the subject. | 11-26-2015 |
Ronald L. Martin, Chesapeake Beach, MD US
Patent application number | Description | Published |
---|---|---|
20100117802 | System and method for providing communications for container security - A system for providing communications for container security is provided. The system includes a sensing system for monitoring the contents of the container; a signal receiving element for receiving sensor data from the sensing system; a control element for analyzing received sensor data; a first transceiver element for receiving signals containing sensor data from within the container and for transmitting those signals outside of the container; and a satellite transceiver element for receiving signals from the first transceiver element and for forwarding the received signals via satellite uplink to a remote location. | 05-13-2010 |
20110037591 | SYSTEM AND METHOD FOR MONITORING A CLOSED CONTAINER - A system for providing communications for container security is provided. The system includes a sensing system for monitoring the contents of the container; a signal receiving element for receiving sensor data from the sensing system; a control element for analyzing received sensor data; a first transceiver element for receiving signals containing sensor data from within the container and for transmitting those signals outside of the container. | 02-17-2011 |
Samuel K. Martin, Burtonsville, MD US
Patent application number | Description | Published |
---|---|---|
20090317499 | Artemisinins in the clinical and veterinary management of kinetoplastid infections - The invention relates to the treatment of kintoplastid infections by administering a pharmaceutical composition containing an extract from the plant | 12-24-2009 |
20140243402 | Artemisinins in the Clinical and Veterinary Management of Kinetoplastid Infextions - The invention relates to the treatment of kintoplastid infections by administering a pharmaceutical composition containing an extract from the plant | 08-28-2014 |
Samuel Kofele Martin, Burtonsville, MD US
Patent application number | Description | Published |
---|---|---|
20130158134 | Use of a safe, green and biodegradable absorptive material in the construction of diapers, feminine hygiene and adult incontinence products and devices - A method of making absorbent core systems for the construction of absorbent articles such as baby care, feminine hygiene or adult incontinence products. The method essentially replaces the traditional synthetic acrylic acid polymer-based hydrophilic material mixed with wood pulp fiber in the absorbent core with a safer, green, biodegradable plant-based material. | 06-20-2013 |
Shannon Martin, Frederick, MD US
Patent application number | Description | Published |
---|---|---|
20130184168 | IMMUNOREACTIVE FRANCISELLA TULARENSIS ANTIGENS - The present invention relates to immunoreactive | 07-18-2013 |
Stuart Martin, Severna Park, MD US
Patent application number | Description | Published |
---|---|---|
20090137473 | INHIBITION OF MICROTUBULE PROTRUSION IN CANCER CELLS - The present invention generally concerns microtubule protrusions in cancer cells, including detached cancer cells, and inhibition of the protrusions. In particular aspects, the inhibition of the protrusions interferes with attachment of the cell to a vessel wall, and in further aspects the cell is killed by forcing it to enter capillaries and be destroyed, for example by shearing. Inhibition by a variety of agents and methods is contemplated. | 05-28-2009 |
20160097769 | MATERIALS AND METHODS FOR ASSAYING LIVING CELLS - The present invention provides a device for assaying living cells comprising a substrate, wherein the substrate comprises one or more tethering molecules which adhere to the substrate and are capable of interacting with cell membranes of the cells, wherein the cells maintain a free-floating, non-adherent character when bound to the one or more tethering molecules. | 04-07-2016 |
Stuart S. Martin, Severna Park, MD US
Patent application number | Description | Published |
---|---|---|
20110021440 | APOPTOTIC PATHWAY TARGETING FOR THE DIAGNOSIS AND TREATMENT OF CANCER - The invention relates to methods of treating cancer. The invention further relates to a method of treating cancer by exploiting apoptotic pathways. The invention particularly relates to regulation of apoptotic pathways in cancerous cells, to metastasis of cancer cells, and to methods of preventing cancer metastasis. | 01-27-2011 |
Ubaldo Martin, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20150104447 | METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING BENRALIZUMAB - Provided herein is are methods of treating Chronic Obstructive Pulmonary Disease (COPD) in a patient, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof. | 04-16-2015 |
Victor Martin, Pasadena, MD US
Patent application number | Description | Published |
---|---|---|
20100263301 | ENERGY-SAVING BAFFLE - The invention concerns an energy-saving baffle. In this regard, the invention may include a baffle of synthetic material that may have insulating properties and a shape and a size to be positioned beneath the roof and attached to framing members that connect a top plate of a wall with an apex of a roof. The baffle may be positioned in proximity of the top plate, wherein the insulating properties and positioning of the synthetic block provide an increase of insulation R-value at or above a predetermined threshold in the area beneath the roof. | 10-21-2010 |